A double blind, randomised, placebo-controlled trial to evaluate the efficacy of metformin to treat preterm pre-eclampsia (PI2 Trial) : Study protocol

Cluver, CatherineWalker, Susan P.Mol, Ben W.Hall, DavidHiscock, RichardBrownfoot, Fiona C.Kaitu'U-Lino, Tu'Uhevaha J.Tong, Stephen2024-03-112024-03-112020-03Cluver, C, Walker, S P, Mol, B W, Hall, D, Hiscock, R, Brownfoot, F C, Kaitu'U-Lino, TU J & Tong, S 2020, 'A double blind, randomised, placebo-controlled trial to evaluate the efficacy of metformin to treat preterm pre-eclampsia (PI2 Trial) : Study protocol', BMJ Open, vol. 9, no. 4, e025809. https://doi.org/10.1136/bmjopen-2018-0258092044-6055https://hdl.handle.net/2164/22953This work is supported by the Mercy Perinatal Foundation, the South African Medical Research Council and the Preeclampsia Foundation. NHMRC provides salary support to ST and BWM. The trial medication was donated by Merck pharmaceuticals.8293935engSDG 3 - Good Health and Well-beingclinical trialsmetforminpre-eclampsiapreeclampsiapreterm preeclampsiatreatmentR MedicineGeneral MedicineRA double blind, randomised, placebo-controlled trial to evaluate the efficacy of metformin to treat preterm pre-eclampsia (PI2 Trial) : Study protocolJournal article10.1136/bmjopen-2018-025809http://www.scopus.com/inward/record.url?scp=85065127480&partnerID=8YFLogxK94